Xenpozyme 4 mg, poudre pour solution à diluer pour perfusion

7680672870014 CH-67287 Puder
Xenpozyme 4 mg, poudre pour solution à diluer pour perfusion
Xenpozyme 4 mg, poudre pour solution à diluer pour perfusion
Xenpozyme 4 mg, poudre pour solution à diluer pour perfusion
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Puder
Galenic group
Spray/Puder

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
29/07/2025
Summary of Product Characteristics
Français
29/07/2025
Summary of Product Characteristics
Italien
29/07/2025

Detailed composition

Substance Quantity Type Category
PRC
4.0 MG Substance Wirkstoff (Principe actif)
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
0.6 MG Substance HBESI

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
67287
Drug name
Xenpozyme, poudre pour solution à diluer pour perfusion
Galenic form
PULPI
ATC Code
A16AB25
Authorization status
Z
Dispensing category
A
First authorization
19/12/2023
Authorization expiration date
18/12/2028
IT Number
07.99.0.
Domain
Human medicine

Package details

Description (FR)
XENPOZYME subst sèche 4 mg flac
Description (DE)
XENPOZYME Trockensub 4 mg Durchstf
Market launch
19/12/2023
Narcotic (BTM)
No

Other package sizes (3)

XENPOZYME subst sèche 20 mg flac
1 DUR
GTIN: 7680672870038
View
None
10 DUR
GTIN: None
Not in V1
None
10 DUR
GTIN: None
Not in V1